These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32827577)

  • 1. PTEN in osteosarcoma: Recent advances and the therapeutic potential.
    Zheng C; Tang F; Min L; Hornicek F; Duan Z; Tu C
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188405. PubMed ID: 32827577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-1908 is upregulated in human osteosarcoma and regulates cell proliferation and migration by repressing PTEN expression.
    Yuan H; Gao Y
    Oncol Rep; 2015 Nov; 34(5):2706-14. PubMed ID: 26328886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGD1 promotes tumor progression and regulates tumor immune response in osteosarcoma via inhibiting PTEN activity.
    Wu W; Jing D; Meng Z; Hu B; Zhong B; Deng X; Jin X; Shao Z
    Theranostics; 2020; 10(6):2859-2871. PubMed ID: 32194840
    [No Abstract]   [Full Text] [Related]  

  • 4. Honokiol suppresses proliferation and induces apoptosis via regulation of the miR‑21/PTEN/PI3K/AKT signaling pathway in human osteosarcoma cells.
    Yang J; Zou Y; Jiang D
    Int J Mol Med; 2018 Apr; 41(4):1845-1854. PubMed ID: 29393336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mxd1 mediates hypoxia-induced cisplatin resistance in osteosarcoma cells by repression of the PTEN tumor suppressor gene.
    Zheng D; Wu W; Dong N; Jiang X; Xu J; Zhan X; Zhang Z; Hu Z
    Mol Carcinog; 2017 Oct; 56(10):2234-2244. PubMed ID: 28543796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-130a promotes the metastasis and epithelial-mesenchymal transition of osteosarcoma by targeting PTEN.
    Chen J; Yan D; Wu W; Zhu J; Ye W; Shu Q
    Oncol Rep; 2016 Jun; 35(6):3285-92. PubMed ID: 27035216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HTRA3 transcriptionally inhibited by FOXP1 suppresses tumorigenesis of osteosarcoma via the PTEN/PI3K/AKT pathway.
    Tong Z; Shen Y; Yuan Q; Yu H
    Biochim Biophys Acta Mol Cell Res; 2023 Oct; 1870(7):119553. PubMed ID: 37527738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copy number gains in EGFR and copy number losses in PTEN are common events in osteosarcoma tumors.
    Freeman SS; Allen SW; Ganti R; Wu J; Ma J; Su X; Neale G; Dome JS; Daw NC; Khoury JD
    Cancer; 2008 Sep; 113(6):1453-61. PubMed ID: 18704985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIX1 reduces the expression of PTEN via activating PI3K/AKT signal to promote cell proliferation and tumorigenesis in osteosarcoma.
    Yu C; Zhang B; Li YL; Yu XR
    Biomed Pharmacother; 2018 Sep; 105():10-17. PubMed ID: 29807230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SLC25A22 Promotes Proliferation and Metastasis of Osteosarcoma Cells via the PTEN Signaling Pathway.
    Chen MW; Wu XJ
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818811143. PubMed ID: 30482097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic and Therapeutic Targeting of PTEN Loss in Bone Malignancies.
    Xi Y; Chen Y
    J Cell Biochem; 2015 Sep; 116(9):1837-47. PubMed ID: 25773992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosmarinic acid exerts an anticancer effect on osteosarcoma cells by inhibiting DJ-1 via regulation of the PTEN-PI3K-Akt signaling pathway.
    Ma Z; Yang J; Yang Y; Wang X; Chen G; Shi A; Lu Y; Jia S; Kang X; Lu L
    Phytomedicine; 2020 Mar; 68():153186. PubMed ID: 32088353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-92a promotes tumor growth of osteosarcoma by targeting PTEN/AKT signaling pathway.
    Xiao J; Yu W; Hu K; Li M; Chen J; Li Z
    Oncol Rep; 2017 Apr; 37(4):2513-2521. PubMed ID: 28260104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIF‑1α‑induced upregulation of lncRNA UCA1 promotes cell growth in osteosarcoma by inactivating the PTEN/AKT signaling pathway.
    Li T; Xiao Y; Huang T
    Oncol Rep; 2018 Mar; 39(3):1072-1080. PubMed ID: 29328452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SLC34A2 Regulates the Proliferation, Migration, and Invasion of Human Osteosarcoma Cells Through PTEN/PI3K/AKT Signaling.
    Liu X; Zhou X; Xu H; He Z; Shi X; Wu S
    DNA Cell Biol; 2017 Sep; 36(9):775-780. PubMed ID: 28777670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic targeting of cancers with loss of PTEN function.
    Dillon LM; Miller TW
    Curr Drug Targets; 2014 Jan; 15(1):65-79. PubMed ID: 24387334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between PTEN and clinical-pathological features of osteosarcoma.
    Zhou J; Xiao X; Wang W; Luo Y
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31270249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1β/nuclear factor-κB signaling promotes osteosarcoma cell growth through the microRNA-181b/phosphatase and tensin homolog axis.
    Wang W; Wang Z; Chen S; Zang X; Miao J
    J Cell Biochem; 2019 Feb; 120(2):1763-1772. PubMed ID: 30977354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the PTEN gene on adhesion, invasion and metastasis of osteosarcoma cells.
    Hu Y; Xu S; Jin W; Yi Q; Wei W
    Oncol Rep; 2014 Oct; 32(4):1741-7. PubMed ID: 25069680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-19a regulates the cell growth and apoptosis of osteosarcoma stem cells by targeting PTEN.
    Zhao D; Chen Y; Chen S; Zheng C; Hu J; Luo S
    Tumour Biol; 2017 May; 39(5):1010428317705341. PubMed ID: 28475001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.